UNLIMITED FREE
ACCESS
TO THE WORLD'S BEST IDEAS

SUBMIT
Already a GlobalSpec user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your GlobalSpec Experience

Finish!
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

CLSI - MM02-A2

Immunoglobin and T-Cell Receptor Gene Rearrangement Assays; Approved Guideline

inactive, Most Current
Organization: CLSI
Publication Date: 1 August 2002
Status: inactive
Page Count: 59
scope:

The use of molecular methods that use deoxyribonucleic acid (DNA) probes in clinical diagnosis presents new challenges to the pathologist. Despite the clear benefits of having another method by which to identify proliferation of monoclonal cell populations, issues of sensitivity and false-positive results mandate the application of stringent laboratory practice. To ensure the success of nucleic acid diagnostics, several key areas warrant attention. This document addresses the following topics as they relate to the direct detection of T- and B-cell gene rearrangements:

• indications for gene rearrangement analysis;

• specimen collection, transport, and processing;

• assessment of specimen adequacy;

• conduct of the gene rearrangement assay;

• sensitivity, specificity, controls, and artifacts;

• quality assurance; and

• interpretation of results.

Document History

MM02-A2
August 1, 2002
Immunoglobin and T-Cell Receptor Gene Rearrangement Assays; Approved Guideline
The use of molecular methods that use deoxyribonucleic acid (DNA) probes in clinical diagnosis presents new challenges to the pathologist. Despite the clear benefits of having another method by which...

References

Advertisement